165 related articles for article (PubMed ID: 14768523)
1. Anaphylactic shock induced by gadoterate meglumine (DOTAREM).
Beaudouin E; Kanny G; Blanloeil Y; Guilloux L; Renaudin JM; Moneret-Vautrin DA
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):382-5. PubMed ID: 14768523
[TBL] [Abstract][Full Text] [Related]
2. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment.
Hasdenteufel F; Luyasu S; Renaudin JM; Paquay JL; Carbutti G; Beaudouin E; Moneret-Vautrin DA; Kanny G
J Allergy Clin Immunol; 2008 Feb; 121(2):527-8. PubMed ID: 17919712
[No Abstract] [Full Text] [Related]
3. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
[No Abstract] [Full Text] [Related]
4. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
5. Anaphylaxis to gadobenate dimeglumine (Multihance): a case report.
Kalogeromitros DC; Makris MP; Aggelides XS; Spanoudaki N; Gregoriou SG; Avgerinou G; Rigopoulos DG
Int Arch Allergy Immunol; 2007; 144(2):150-4. PubMed ID: 17536224
[TBL] [Abstract][Full Text] [Related]
6. Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations.
De Ridder F; De Maeseneer M; Stadnik T; Luypaert R; Osteaux M
JBR-BTR; 2001 Aug; 84(4):150-2. PubMed ID: 11688727
[TBL] [Abstract][Full Text] [Related]
7. Gadoteridol-induced anaphylaxis - not a class allergy.
Galera C; Pur Ozygit L; Cavigioli S; Bousquet PJ; Demoly P
Allergy; 2010 Jan; 65(1):132-4. PubMed ID: 19796195
[No Abstract] [Full Text] [Related]
8. Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine.
Meuli RA; Maeder P
AJR Am J Roentgenol; 1996 Mar; 166(3):729. PubMed ID: 8623674
[No Abstract] [Full Text] [Related]
9. Fatal reaction to gadopentetate dimeglumine.
Jordan RM; Mintz RD
AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
[No Abstract] [Full Text] [Related]
10. Frequency and Severity of Acute Allergic-Like Reactions to Intravenously Administered Gadolinium-Based Contrast Media in Children.
Forbes-Amrhein MM; Dillman JR; Trout AT; Koch BL; Dickerson JM; Giordano RM; Towbin AJ
Invest Radiol; 2018 May; 53(5):313-318. PubMed ID: 29337841
[TBL] [Abstract][Full Text] [Related]
11. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
12. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
Witte RJ; Anzai LL
AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
[TBL] [Abstract][Full Text] [Related]
13. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
Tishler S; Hoffman JC
AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
[No Abstract] [Full Text] [Related]
14. [Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
Chanalet S; Masson B; Boyer L; Laffont J; Bruneton JN
J Radiol; 1995 Jul; 76(7):417-21. PubMed ID: 7473375
[TBL] [Abstract][Full Text] [Related]
15. Clinical safety of gadopentetate dimeglumine.
Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
[TBL] [Abstract][Full Text] [Related]
16. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
[No Abstract] [Full Text] [Related]
17. Safety of gadoterate meglumine in children younger than 2 years of age.
Farmakis SG; Hardy AK; Mahmoud SY; Wilson-Flewelling SA; Tao TY
Pediatr Radiol; 2020 May; 50(6):855-862. PubMed ID: 32055917
[TBL] [Abstract][Full Text] [Related]
18. Anaphylactic reaction and cardiac arrest due to gadobenate dimeglumine.
Virtos M; Ruiz S; Mokrane FZ; Rousseau H; Georges B; Fourcade O; Conil JM
Anaesth Crit Care Pain Med; 2015 Aug; 34(4):247-8. PubMed ID: 26004876
[No Abstract] [Full Text] [Related]
19. Anaphylaxis after first exposure to gadoterate meglumine: a case report and literature review.
Bianchi L; Hansel K; Marietti R; Tramontana M; Stingeni L
J Allergy Clin Immunol Pract; 2018; 6(6):2124-2126. PubMed ID: 29559210
[No Abstract] [Full Text] [Related]
20. Laryngospasm after administration of gadopentetate dimeglumine.
Omohundro JE; Elderbrook MK; Ringer TV
J Magn Reson Imaging; 1992; 2(6):729-30. PubMed ID: 1446118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
